|
BREAKTHROUGH
HUMAN GENOME GENETIC VARIATION AND CLINIC |
|
|
|
|
|
|
Incorporating Genetic Testing for Guided Prevention of Contralateral Breast Cancer
|
|
|
|
|
|
|
Minimal residual disease in breast cancer: Can it be used as prognostic marker? |
|
|
|
|
|
|
Preventing Contralateral Breast Cancer |
|
|
|
|
|
|
Cancer origin and Metastasis - Does Local Control Affect Overall Survival for Solid Cancer? |
|
|
|
|
|
|
Endoscopic Mucosal Resection - Is safe and Effective for Early Diffuse-type Gastric Cancer? |
|
|
|
|
|
|
Benefits and harms in avoiding Axilla Lymphadenectomy in Breast Cancer |
|
|
|
25 - 27 |
|
|
Targeting HER2 Breast Cancer With Trastuzumab, Lapatinib and Other Novel Agents: Clinical Success and Resistance |
|
|
|
28 - 44 |
|